BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38556719)

  • 1. Implementation of a light therapy team to administer photobiomodulation therapy: A standardized protocol to prevent and treat oral mucositis in the pediatric hematopoietic stem cell transplant population.
    Magee K; Robins J; Staton S; Llaurador G; Stevens AM
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30966. PubMed ID: 38556719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New photobiomodulation protocol prevents oral mucositis in hematopoietic stem cell transplantation recipients-a retrospective study.
    Weissheimer C; Curra M; Gregianin LJ; Daudt LE; Wagner VP; Martins MAT; Martins MD
    Lasers Med Sci; 2017 Dec; 32(9):2013-2021. PubMed ID: 28840382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation: which approach is more effective?
    Rupel K; Cornacchia A; Poiani M; Mohamed S; De Bellis E; Ballerini M; Bogdan Preda TM; Poropat A; Di Lenarda R; Zaja F; Biasotto M; Ottaviani G
    Support Care Cancer; 2024 Mar; 32(3):208. PubMed ID: 38438625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial.
    Ramos-Pinto MB; de Lima Gusmão TP; Schmidt-Filho J; Jaguar GC; Martins MD; Alves FA
    Support Care Cancer; 2021 Nov; 29(11):6495-6503. PubMed ID: 33905011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy.
    Eduardo Fde P; Bezinelli LM; de Carvalho DL; Lopes RM; Fernandes JF; Brumatti M; Vince CS; de Azambuja AM; Vogel C; Hamerschlak N; Correa L
    Pediatr Transplant; 2015 May; 19(3):316-25. PubMed ID: 25677170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of Photobiomodulation for the Prevention and Treatment of Oral Mucositis.
    Pritchard M; Ogg SW; Bosi J; Mandrell BN
    J Pediatr Hematol Oncol Nurs; 2024; 41(2):107-113. PubMed ID: 38377968
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of photobiomodulation therapy on reducing the chemo-induced oral mucositis severity and on salivary levels of CXCL8/interleukin 8, nitrite, and myeloperoxidase in patients undergoing hematopoietic stem cell transplantation: a randomized clinical trial.
    Salvador DRN; Soave DF; Sacono NT; de Castro EF; Silva GBL; E Silva LP; Silva TA; Valadares MC; Mendonça EF; Batista AC
    Lasers Med Sci; 2017 Nov; 32(8):1801-1810. PubMed ID: 28664388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Window therapeutic of extraoral photobiomodulation for prevention of oral mucositis in HSCT patients: additional arm.
    da Cruz Santos LB; Ramos-Pinto MB; Zerbato RM; Ferreira MEMG; Schmidt-Filho J; Martins MD; Alves FA
    Support Care Cancer; 2023 Dec; 32(1):27. PubMed ID: 38097854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantation.
    Stocker N; Baltes V; Bellaiche S; Brouillard F; Belmoufid N; Rousseau C; Bonnin A; Van de Wyngaert Z; Ricard L; Banet A; Malard F; Duléry R; Mohty M; Brissot E
    Support Care Cancer; 2022 Oct; 30(10):8211-8216. PubMed ID: 35810217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal of a prophylactic photobiomodulation protocol for chemotherapy-induced oral and oropharyngeal mucositis: a randomized clinical trial.
    Heimlich FV; de Arruda JAA; Pereira NM; Faria LDS; Abreu LG; Ferreira MVL; Kakehasi FM; Travassos DV; Silva TA; Mesquita RA
    Lasers Med Sci; 2023 Oct; 38(1):245. PubMed ID: 37889325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines.
    Zadik Y; Arany PR; Fregnani ER; Bossi P; Antunes HS; Bensadoun RJ; Gueiros LA; Majorana A; Nair RG; Ranna V; Tissing WJE; Vaddi A; Lubart R; Migliorati CA; Lalla RV; Cheng KKF; Elad S;
    Support Care Cancer; 2019 Oct; 27(10):3969-3983. PubMed ID: 31286228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.
    Legert KG; Remberger M; Ringdén O; Heimdahl A; Dahllöf G
    Support Care Cancer; 2014 Aug; 22(8):2133-40. PubMed ID: 24647488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update.
    Patel P; Robinson PD; Baggott C; Gibson P; Ljungman G; Massey N; Ottaviani G; Phillips R; Revon-Rivière G; Treister N; White M; Cabral S; Dupuis L; Sung L
    Eur J Cancer; 2021 Sep; 154():92-101. PubMed ID: 34252760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
    Vitale MC; Modaffari C; Decembrino N; Zhou FX; Zecca M; Defabianis P
    Lasers Med Sci; 2017 Aug; 32(6):1423-1428. PubMed ID: 28664389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the understanding and management of mucositis during stem cell transplantation.
    Bowen JM; Wardill HR
    Curr Opin Support Palliat Care; 2017 Dec; 11(4):341-346. PubMed ID: 28984677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation.
    Bezinelli LM; de Paula Eduardo F; da Graça Lopes RM; Biazevic MG; de Paula Eduardo C; Correa L; Hamerschlak N; Michel-Crosato E
    Hematol Oncol; 2014 Mar; 32(1):31-9. PubMed ID: 23625880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral mucositis in paediatric cancer patients undergoing allogeneic hematopoietic stem cell transplantation preventively treated with professional dental care and photobiomodulation: Incidence and risk factors.
    Miranda-Silva W; da Fonseca FP; Gomes AA; Mafra ABB; Rocha V; Fregnani ER
    Int J Paediatr Dent; 2022 Mar; 32(2):251-263. PubMed ID: 34115428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial.
    Kamsvåg T; Svanberg A; Legert KG; Arvidson J; von Essen L; Mellgren K; Toporski J; Winiarski J; Ljungman G
    Support Care Cancer; 2020 Oct; 28(10):4869-4879. PubMed ID: 31993753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.